Bizcommunity on MSN
Aspen Pharmacare reaches €25m settlement in mRNA contract dispute
Aspen Pharmacare said it had reached a €25m settlement in a contractual dispute with a client over a manufacturing and ...
By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers have found a way to force tumors to trigger their own destruction.
Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting ...
Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has been dosed in a Phase 1/2 study of mRNA-2808, the ...
Scientists have developed an experimental mRNA vaccine that, when combined with existing immunotherapy drugs, could 'teach' ...
MRNA research enabled the remarkably fast production of COVID-19 vaccine candidates in the pandemic. But more broadly, the ...
Researchers found that COVID-19 mRNA vaccines significantly increased survival in lung and skin cancer patients undergoing ...
The mRNA vaccines developed to fight COVID-19 during the pandemic "did have a very important impact in decreasing hospitalizations, severe pneumonia and death." ...
A new preliminary study published in Nature suggests that COVID-19 vaccines might actually boost the immune system to make ...
FRIDAY, Oct. 24, 2025 (HealthDay News) — The mRNA technology powering some COVID vaccines may hold a surprising benefit for ...
The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results